Feasibility of circulating tumor DNA testing in hepatocellular carcinoma

BACKGROUND: Advancement of technologies enabling clinical assessment of circulating tumor DNA (ctDNA) are allowing for assessment of tumor specific genetic alterations in patients. This holds incredible promise for early detection of disease, serial monitoring of tumor heterogeneity, elucidation of...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Gastrointest Oncol
Main Authors: Mody, Kabir, Kasi, Pashtoon Murtaza, Yang, Ju Dong, Surapaneni, Phani Keerthi, Ritter, Ashton, Roberts, Ali, Nagy, Rebecca, Borad, Mitesh J.
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2019
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6657310/
https://ncbi.nlm.nih.gov/pubmed/31392055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2019.02.10
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki